Glomac Bhd ("Glomac") reported better-than-expected earnings due to more favourable product mix. Despite slow start in new property sales, management targets to launch RM385 mil in 2HFY25 to exceed FY24 new sales of RM360 mil. We maintain our HOLD recommendation on the stock with higher target price of RM0.44 from RM0.40 previously, based on 45% discount to RNAV and unchanged neutral ESG rating of 3 stars.
Source: AmInvest Research - 28 Nov 2024
Chart | Stock Name | Last | Change | Volume |
---|
2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMAC2025-01-27
GLOMACCreated by AmInvest | Jan 24, 2025